Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0851

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer ; day:31 ; month:3 ; year:2021 ; pages:1-12
Cancer immunology immunotherapy ; (31.3.2021), 1-12

Creator: Witt, Kristina
Evans-Axelsson, Susan
Lundqvist, Andreas
Johansson, Martin
Bjartell, Anders
Hellsten, Rebecka

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00262-021-02915-6

URN: urn:nbn:de:101:1-2021051618471366694029

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Witt, Kristina
Evans-Axelsson, Susan
Lundqvist, Andreas
Johansson, Martin
Bjartell, Anders
Hellsten, Rebecka
SpringerLink (Online service)

Other Objects (12)

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Related objects

Reset password